LB
Almirall, S.A.
LBTSF · OTC
$15.35 -0.78% (-$0.12)
Market Cap 2.84B €
P/E Ratio 67.48x
Div. Yield 1.09%
ROE 2.84%
Bulios Fair Price
$11.4
25.7% downside
Trenutna cena
$15.35
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica LBTSF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
7/9Valuation
34 /100
Fair P/E 67.48x
P/B 1.92x
EV/EBITDA 12.41x
Growth
11 /100
Declining EPS growth 65.15%
Book val. growth 0.99%
Rev. growth 0.31%
Profitability
42 /100
Moderate Gross margin 76.87%
FCF margin 2.77%
Net margin 3.90%
Quality
15 /100
Poor ROIC 2.46%
Asset turnover 0.46x
ROE 2.84%
Debt
87 /100
Low Debt/Equity 0.23x
Net debt/EBITDA -0.18x
Current ratio 2.55x
Stability
3 /100
Unstable Beta 0.18x
Profitable years 1
Rev. volatility 69.38%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LBTSF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Carlos Gallardo Piqué
Employees
2,026
Headquarters
Barcelona
Prihajajoči dogodki
09 NOV.
Earnings
Upcoming earnings report